Saturday, December 3, 2022
This conference has already taken place.
Description
The cost of chronic liver disease in our healthcare system
is significant. We anticipate that costs will continue to rise as we encounter
many more patients with diseases like NAFLD which is fast becoming the main
reason for liver transplantation in the United States. The burden of liver
disease and liver cancer is expected to further increase in the years to come. Some
practitioners are unaware of updated interventions in prevention, early
detection, and treatment to manage all aspects of the disease.
Dates and Times
Start: 12/3/2022 7:15 AM
End: 12/3/2022 2:00 PM
Objectives
At the conclusionof this activity, learners will be able to:
1. Discuss emerging therapies and updated
management for patients with NAFLD
2. Discuss therapies for management of primary biliary cholangitis
3.
Discuss updates on management of portal hypertension
4. Discuss updates on diagnosis and management of liver cancer
5.
Discuss advanced strategies for better outpatient care of cirrhotic and
patients and preventing re-admission to the hospital
6.
Discuss emerging therapies for patients undergoing liver transplant
7.
Discuss importance of multi-disciplinary teams in caring for patients with
chronic liver disease
Agenda
715am-Registration/Breakfast/Visit Exhibits
7:50am-Welcome/Opening Remarks
Session 1
8-830: AASLD Update 2022
830-9: Current and Future Therapies for NAFLD
9-930: Nutrition and Frailty in Cirrhosis
930-10: Changing Landscape in Liver Cancer and Cholangiocarcinoma
10:00-10:15: Q&A Session 1
1045-11: Break
Session 2
11-1130: Management of Portal Hypertensive Bleeding
1130-12: Expanding the Donor Pool in Liver Transplantation
12-1230: Long-term care for the post-transplant patient
1230-1245: Q&A Session 2
1-2 Lunch and Learn: Case Presentations and Discussions
2pm Adjourn
Pricing
| Tier | Price |
|---|---|
| This is a free event | $0.00 |
Speakers
Location
James Cancer Hospital and Solove Research Institute (Also streaming live- details to come closer to the event)
460 W 10th Ave
Room L035
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.